Profusa, Inc (PFSA): יחס שווי פעילות לרווח לפני ריבית, מסים ופחת

The share price of Profusa Inc (PFSA) visualized below demonstrates an EV/EBITDA of 0.00. Biosensor production capacities are functioning without disruption, strictly adhering to the development schedule. However, export restrictions and component shortages are hindering expansion into emerging markets. Business stability is ensured by a combination of proprietary sterile laboratories in the US and the engagement of external contractors for final device assembly.

This indicator compares the total enterprise value with its operating profit before depreciation and amortization, allowing for an assessment of the real value of assets regardless of debt load and tax regime. For Profusa Inc (PFSA), which is protected by DARPA government grants, the EV/EBITDA valuation multiple serves as a filter that separates the fundamental value of biosensor developments from market noise and inflationary risks.